| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 119.22M | — |
| Operating expense | — | — |
| Net income | 54.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KRYS returned +130.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +40.6% |
| 1 year | +130.3% |
| 5 years | +498.2% |
| All-time high | $371.67 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KRYS would be worth today ›No. Krystal Biotech, Inc. has not paid a dividend in the past 12 months.
Krystal Biotech, Inc. stock trades on NASDAQ under the ticker symbol KRYS.
Krystal Biotech, Inc. is part of the Healthcare sector.
Krystal Biotech, Inc. has a market cap of 10.26B USD, based on the latest quote.
Krystal Biotech, Inc. is expected to report earnings around Nov 2, 2026. That date is an estimate and has not been confirmed by the company.
